Skip to content

Reducing Diabetes Risk Factors in American Indian Children: Tribal Turning Point

Reducing Diabetes Risk Factors in American Indian Children: Tribal Turning Point

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03573856
Acronym
TTP
Enrollment
188
Registered
2018-06-29
Start date
2018-07-01
Completion date
2023-09-30
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight/Obesity

Brief summary

This study will evaluate a behavioral intervention designed to reduce risk factors for type 2 diabetes in American Indian youth aged 7-10 years.

Detailed description

The objectives of tis study are to rigorously evaluate the effect of Tribal Turning Point (TTP) on diabetes risk factors in Native youth. The investigators will enroll up to 360 youth who are aged 7-10 years, overweight/obese (BMI \>85th percentile), self-identify as American Indian, and have \>1 parent/primary caregiver willing to actively participate in the program. Within each community, youth will be randomized to the TTP program or a general health and safety control program. The multi-component TTP intervention is a youth-centered adaptation of the Diabetes Prevention Program designed to reduce diabetes risk factors by improving activity and dietary behaviors. Informed by the pediatric weight management literature, the 12-month intervention includes 12 active learning group classes, 7 individual youth/parent motivational interviewing counseling sessions, and community-specific resource toolboxes. In this trial, the investigators will assess the effect of TTP on anthropometric, metabolic, and behavioral risk factors for type 2 diabetes at the end of the intervention (12mo) and after 1 year of follow-up (24mo).

Interventions

BEHAVIORALActive Living

Participants will be provided with education and support for diet and lifestyle modification related to healthy eating and active living.

Participants will be provided with education related to general health and safety topics.

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
7 Years to 10 Years
Healthy volunteers
Yes

Inclusion criteria

* self-identify as American Indian * BMI \>=85th percentile for age and sex * have at least one parent/primary caregiver (parent) willing to actively participate

Exclusion criteria

* diabetes * any serious youth/parent health concerns that would interfere with participation * plans to move out of the area during the study period

Design outcomes

Primary

MeasureTime frame
Change from 0 to 12 months in Body Mass Index (BMI)12 months
Change from 0 to 12 months in fasting insulin12 months

Secondary

MeasureTime frame
Change from 0 to 12 months in BMI z-score12 months
Change from 0 to 12 months in waist circumference12 months
Change from 0 to 12 months in hemoglobin A1c12 months
Change from 0 to 12 months in fasting glucose12 months

Other

MeasureTime frameDescription
Change from 0 to 12 months in fruit/vegetable intake12 monthsProportion consuming 5+ servings of fruits/vegetables daily
Potential for sustained delivery12 monthsQualitative factors related to potential for sustained delivery
Change from 0 to 12 months in physical activity12 monthsProportion engaging in 1+ hour of moderate-vigorous physical activity daily
Change from 0 to 12 months in screen time12 monthsProportion watching 2 hours or less of screen time daily
Change from 0 to 12 months in sugary beverage intake12 monthsProportion consuming 0 servings of sugary beverages daily
Participant engagement12 monthsQualitative factors related to participant engagement
Program implementation12 monthsQualitative factors related to program implementation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026